Biomx Inc (PHGE)

Biomx Inc (PHGE) is a company listed on the AMEX.

As of Oct 8, 2026: market cap $5M; returns 1 week -24.2%, 1 year -99.7%.

BiomX Inc. is a clinical-stage biotechnology company focused on developing phage therapies to target and destroy harmful bacteria associated with chronic diseases. Their business model centers around advancing phage-based candidates through clinical development, with revenue primarily from R&D collaborations, grants, and licensing agreements.

Groups PHGE belongs to

• Recent Reverse Splits
• Defense Technology
• Aerospace & Defense
• Defense
• National Security
• Government Contractor
• Defense Industry
• Drones
• Public Safety and Security
• Artificial Intelligence
• Industrials Sector
• Infrastructure

PHGE financial model: income statement, cash flow and balance sheet